Avita Medical Stock Math Operators Price Series Division

Stocks . USA . 
Stock . Avita Medical
RCEL Stock  USD 4.40  -0.18  -3.93%   
The math operators module provides an execution environment for Price Series Division operator and related indicators on Avita Medical and Lucid Diagnostics. Signals here center on relative price relationships between Avita Medical and Lucid Diagnostics alongside volatility and performance references.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Avita Medical Price Series Division is a division of Avita Medical price series and its benchmark/peer.

Avita Medical Technical Analysis Modules

Most technical analysis of Avita Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Avita from various momentum indicators to cycle indicators. When you analyze Avita charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Stock Overview, Methodology & Data Sources

AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 116 people. The profile for Avita Medical integrates fundamentals, price behavior, and sector exposure. Price behavior may show elevated responsiveness to broader market cycles. Avita Medical has a market cap of 140.29 M, ROE of -17.46%.

Methodology

Unless otherwise specified, financial data for Avita Medical is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Avita (USA Stocks:RCEL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Avita Medical is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include HSBC Global Research, Wells Fargo Securities, Goldman Sachs, Guggenheim Securities, RBC Capital Markets, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Avita Medical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash position to determine if your portfolio needs rebalancing
All  Next Launch Module

Avita Medical pair trading

Pair trading with Avita Medical can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Avita Medical Pair Trading

Avita Medical Pair Trading Analysis

Using correlated positions as Avita Medical substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track Avita Medical closely enough to maintain equivalent risk and return.
The correlation of Avita Medical with other assets is a key diversification metric. Pairing Avita Medical with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for Avita Medical can be used to frame hedging context. The view can be extended across sectors or other related groups.
Pair CorrelationCorrelation Matching

More Resources for Avita Stock Analysis

A structured review of Avita Medical often starts with core financial statements and trend context. Ratios and trend metrics help frame Avita Medical's operating context. Key reports that frame Avita Medical Stock are listed below:
How To Invest In Avita
Details
Is Avita Stock a good investment?
Details
What is Avita Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Avita Medical has a market cap of 140.29 M, operating margin of -59.09%, ROE of -17.46%. Use Your Equity Center to explore allocation context. This includes a position in Avita Medical in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Avita Stock, please use our How to Invest in Avita Medical guide.
Analysis related to Avita Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
 Earnings Share
-1.74
 Revenue Per Share
2.57
 Quarterly Revenue Growth
-0.04
 Return On Assets
-0.39
 Return On Equity
-17.46
The market value of Avita Medical is measured differently than book value, which reflects Avita accounting equity. Avita Medical's market capitalization is 140.29 M. With a P/B ratio of 11.77, the market values Avita Medical well above its book equity. Enterprise value stands at 174.9 M. Value and price for Avita Medical are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Analysis
Details
Earnings
Projections
Details
Note that Avita Medical's intrinsic value and market price are different measures derived from different inputs. For Avita Medical, key inputs include a P/B ratio of 11.77, a profit margin of -67.85%, ROE of -17.46%, and revenue of 71.61 M. Market price reflects the current exchange level formed by active bids and offers.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY